Asia Pacific Apr 12, 2021
China considering mixing COVID-19 vaccines to boost protection rate
The move comes after Beijing's top disease official said the country's available vaccines "don't have very high rates of protection."
China considering mixing COVID-19 vaccines to boost protection rate
The move comes after Beijing's top disease official said the country's available vaccines "don't have very high rates of protection."
Japanese drug regulator to fast-track any modified vaccines to fight variants
Vaccines targeting new variants of the coronavirus won't require domestic clinical trials if the production process and handling of the shots are similar to those of the original.
One of Taiwan’s few allies weighs embracing China for vaccines
As poor nations struggle to get their hands on vaccines, a thinly-populated South American country finds its chances linked to its unexpected role in tensions between the U.S. and China.
Pfizer and Moderna vaccines highly effective after first shot in real-world use, study finds
The results validate earlier studies that had indicated the vaccines begin to work soon after a first dose, and confirm that they also prevent asymptomatic infections.
Manslaughter probes in Italy worsen AstraZeneca vaccine troubles
Two doctors and a nurse in Sicily were placed under investigation following the sudden death of a navy officer hours after he received the shot.
AstraZeneca’s pain grows as U.S. questions beleaguered COVID-19 vaccine
U.S. trial data showing the firm's shot to be highly effective was a welcome reprieve this week, but the good news lasted less than a day.
Japanese firms launch domestic clinical trials for COVID-19 vaccines
Even as Daiichi Sankyo and KM Biologics begin work to prove their shots' efficacy and safety, the public is unlikely to have access to them until fiscal 2022 at the earliest.
AstraZeneca may have given outdated vaccine data, U.S. agency says
AstraZeneca PLC may have released outdated information about its COVID-19 vaccine trial, giving an "incomplete” view of the efficacy of the shot, said the leading U.S. agency on infectious disease. The Data and Safety Monitoring Board, charged with ensuring the safety and accuracy of AstraZeneca’s ...
AstraZeneca's U.S. trial data a confidence booster for COVID-19 shot
The data paves the way for potential emergency authorization in the United States and boosts confidence in the shot after setbacks in Europe.
Trials and transparency stand in way of Japan's acquisition of non-Western shots
With domestically developed vaccines some way off and regular inoculations a possibility, Japan may need to look to Russia and China to secure enough shots.
Taiwan premier gets AstraZeneca shot as island starts vaccine campaign
Taiwan Premier Su Tseng-chang received the AstraZeneca COVID-19 shot on Monday, having volunteered to be first in line to underscore government confidence in the vaccine's safety as the island began its inoculation campaign. "I have just finished getting the injection, there is no pain at ...
Vaccine battle heats up with EU ready to halt U.K. shipments
Both sides have blamed each other for export curbs and nationalism, posing a risk to the fragile post-Brexit trade relationship agreed on only in December.